TAVI Market is Predicted to Reach USD 16 Billion Registering a CAGR of 15%

TAVI Market is Predicted to Reach USD 16 Billion Registering a CAGR of 15%

According to Next Move Strategy Consulting, the TAVI Market is predicted to reach USD 16 billion registering a CAGR of 15% till 2030. The global Transcatheter Aortic Valve Implantation (TAVI) Market is poised for substantial growth, driven by an aging population and the increasing prevalence of cardiovascular diseases. TAVI, a minimally invasive procedure designed to treat severe aortic stenosis, has gained traction as an alternative to traditional open-heart surgery, especially for high-risk and elderly patients who may not be candidates for conventional surgical approaches.

This market expansion is fueled by advancements in medical technology, rising demand for minimally invasive procedures, and supportive regulatory environments. As a result, TAVI is transforming the cardiovascular field, offering improved patient outcomes with reduced recovery times, which is particularly beneficial for older adults.

Download a FREE Sample Report: https://www.nextmsc.com/tavi-market/request-sample

Key Market Drivers:

  1. Growing Prevalence of Aortic Stenosis: The increasing incidence of severe aortic stenosis, particularly among the elderly, is a primary driver for TAVI procedures, as it offers a less invasive alternative for those at high surgical risk.
  2. Technological Advancements in TAVI Devices: Continuous innovation in valve design and delivery systems has enhanced the efficacy and safety of TAVI, making it more accessible and effective for a broader patient population.
  3. Increased Demand for Minimally Invasive Procedures: Patients and healthcare providers are shifting towards minimally invasive techniques, which reduce hospital stays and improve recovery times compared to traditional open-heart surgery.
  4. Supportive Regulatory Approvals: Favorable regulatory guidelines and approvals for new TAVI devices are encouraging more healthcare facilities to adopt this approach, driving market growth.

Market Segmentation:

The TAVI market can be segmented by approach, end user, and geography:

  • By Approach:
    • Transfemoral (TF) Approach: The most commonly used method, as it is less invasive and allows access via the femoral artery.
    • Transapical (TA) Approach: Utilized when transfemoral access is not feasible, typically involving a small incision in the chest.
    • Transaortic (TAo) Approach: Involves a minimally invasive incision near the sternum, primarily used in complex cases where other approaches are unsuitable.
  • By End User:
    • Hospitals: Represent the largest segment, with advanced cardiovascular departments that perform TAVI procedures regularly.
    • Ambulatory Surgical Centers (ASCs): ASCs are gaining popularity as they offer cost-effective care with shorter patient recovery times.
  • Geographical Insights:
    • North America dominates the market due to advanced healthcare infrastructure, high awareness, and a large elderly population.
    • Europe is witnessing substantial growth, supported by favorable healthcare policies and high incidence rates of cardiovascular diseases.
    • Asia-Pacific is expected to see the fastest growth, with rising healthcare investments and increasing access to advanced medical technology.

Inquiry Before Buying: https://www.nextmsc.com/tavi-market/inquire-before-buying

Challenges in the Market:

While the TAVI market holds promising growth potential, high procedure costs and limited accessibility in low- and middle-income countries remain key challenges. Additionally, the need for specialized training for healthcare professionals to conduct TAVI procedures can impact adoption rates, especially in regions with less developed healthcare infrastructure.

Key Players in the Market:

Leading companies in the TAVI market are investing in R&D and forming strategic partnerships to expand their portfolios and enhance procedure effectiveness. Major players include:

  • Abbott
  • Meril Life Sciences Pvt. Ltd
  • Boston Scientific Corporation
  • JenaValve
  • Edwards Lifesciences Corporation
  • Medtronic
  • Venus Medtech (Hangzhou) Inc
  • Bracco
  • Peijia Medical Limited
  • Blue Sail Medical Co. Ltd

Conclusion:

As the burden of aortic stenosis continues to rise, the TAVI market is expected to expand significantly over the coming years. The combination of technological advancements, growing awareness, and increased preference for minimally invasive cardiovascular procedures positions TAVI as a leading option for treating severe aortic stenosis worldwide.

Also, Browse Related Reports:

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog